The data (such as it is) points to two months of really strong immunity following recovery, the following two months decent, then a steady decline out to perhaps 8-9 mos, but definstely not really good immunity for that entire period. Caveats a'pleanty - there's a lot of variation out past those first two months for any given individual's circumstances and variant exposure.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.